Jinhai Medical (2225) and Medtronic Changzhou Enter Strategic Cooperation

Bulletin Express
2025/11/06

Jinhai Medical Technology Limited (Stock Code: 2225) announced that its indirect wholly owned subsidiary, Jinhai Technology Development (Shanghai) Co., Ltd., has signed a strategic cooperation framework agreement with Medtronic Changzhou Medical Device Co., Ltd., an indirect wholly owned subsidiary of Medtronic. The agreement, which runs for one year from 6 November 2025 and can be renewed 30 days before expiry, focuses on promoting real-time navigation and tracking spinal endoscope techniques in clinical applications across the PRC.

Under the agreement, both parties will explore developing an integrated solution for navigated spinal endoscopy centered on clinical needs. They plan to invest resources in academic exchange activities to foster technological advancements, as well as provide each other with endoscope prototypes to support demonstrations, trainings, and marketing. Although these areas of cooperation are not yet legally binding, they establish a framework for future formal agreements once all conditions are met.

Jinhai Medical Technology Limited is principally involved in manpower outsourcing, dormitory services, IT services, construction ancillary services, and minimally invasive surgery solutions. Jinhai Technology Development (Shanghai) Co., Ltd. specializes in endoscope products. Medtronic Changzhou engages in the manufacture and sales of medical devices. Both parties have stated that they are independent from each other in ownership and operation.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10